Cargando…
Recruitment to a large scale randomised controlled clinical trial in primary care: the Helicobacter Eradication Aspirin Trial (HEAT)
BACKGROUND: The Helicobacter Eradication Aspirin Trial (HEAT) is a multicentre, double blind, randomised controlled trial investigating whether Helicobacter (H.) pylori eradication reduces hospitalisation for peptic ulcer bleeding. Recruited participants were aged 60 and over and taking aspirin (≤32...
Autores principales: | Stevenson, Diane J., Avery, Anthony J., Coupland, Carol, Hobbs, F. D. Richard, Kendrick, Denise, Moore, Michael V., Morris, Clive, Rubin, Greg P., Smith, Murray D., Hawkey, Christopher J., Dumbleton, Jennifer S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8842965/ https://www.ncbi.nlm.nih.gov/pubmed/35164864 http://dx.doi.org/10.1186/s13063-022-06054-w |
Ejemplares similares
-
The Helicobacter Eradication Aspirin Trial (HEAT): A Large Simple Randomised Controlled Trial Using Novel Methodology in Primary Care
por: Dumbleton, Jennifer S., et al.
Publicado: (2015) -
The Value of Helicobacter Eradication in Long-term Aspirin Users
por: Cuzick, Jack
Publicado: (2018) -
Aspirin to target arterial events in chronic kidney disease (ATTACK): study protocol for a multicentre, prospective, randomised, open-label, blinded endpoint, parallel group trial of low-dose aspirin vs. standard care for the primary prevention of cardiovascular disease in people with chronic kidney disease
por: Gallagher, Hugh, et al.
Publicado: (2022) -
Feasibility of conducting a randomized, placebo-controlled study assessing whether omega-3 fatty acids prevent gout flares when starting urate-lowering treatment
por: Abhishek, Abhishek, et al.
Publicado: (2022) -
Modification of gastric cancer risk associated with proton pump inhibitors by aspirin after Helicobacter pylori eradication
por: Cheung, Ka Shing, et al.
Publicado: (2018)